Josh Cohen
Fundador en AMYLYX PHARMACEUTICALS, INC. .
Fortuna: 6 M $ al 31/05/2024
Perfil
Joshua B.
Cohen is the founder of Amylyx Pharmaceuticals, Inc., where he holds the title of Co-Chief Executive Officer & Executive Director since 2014.
He is also the founder of Brown Biotechnology Investment Group.
Mr. Cohen's current job is as a Director at Practice XYZ LLC.
Mr. Cohen's education includes an undergraduate degree from Brown University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/04/2024 | 3 202 852 ( 4.71% ) | 6 M $ | 31/05/2024 |
Cargos activos de Josh Cohen
| Empresas | Cargo | Inicio |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Fundador | 01/01/2013 |
Practice XYZ LLC
 Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Josh Cohen.
| Empresas | Cargo | Fin |
|---|---|---|
| Brown Biotechnology Investment Group | Fundador | - |
Formación de Josh Cohen.
| Brown University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Practice XYZ LLC
Practice XYZ LLC Internet Software/ServicesTechnology Services Practice XYZ, Inc. offers online platform which supports to share best practice videos. It offers corporate training, professional training, e-learning, online education, simulation training and video based training. The company was founded by Paul Tzen, Emily Foote and Karl S. Okamoto in 2011 and is headquartered in Philadelphia, PA. | Technology Services |
| Brown Biotechnology Investment Group |
- Bolsa de valores
- Insiders
- Josh Cohen
